Baxter International Past Earnings Performance
Past criteria checks 0/6
Baxter International's earnings have been declining at an average annual rate of -50.2%, while the Medical Equipment industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 7.6% per year.
Key information
-50.2%
Earnings growth rate
-49.8%
EPS growth rate
Medical Equipment Industry Growth | 12.9% |
Revenue growth rate | 7.6% |
Return on equity | -0.8% |
Net Margin | -0.5% |
Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Baxter International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 14,813 | -76 | 3,495 | 655 |
30 Sep 23 | 15,280 | 225 | 3,484 | 642 |
30 Jun 23 | 15,181 | -2,817 | 3,491 | 628 |
31 Mar 23 | 15,068 | -2,440 | 3,513 | 611 |
31 Dec 22 | 14,506 | -2,666 | 3,550 | 599 |
30 Sep 22 | 14,275 | -2,568 | 3,435 | 580 |
30 Jun 22 | 13,892 | 876 | 3,212 | 562 |
31 Mar 22 | 13,396 | 992 | 2,957 | 553 |
31 Dec 21 | 12,146 | 1,022 | 2,605 | 530 |
30 Sep 21 | 12,451 | 1,214 | 2,530 | 528 |
30 Jun 21 | 12,197 | 1,120 | 2,460 | 521 |
31 Mar 21 | 11,817 | 1,068 | 2,370 | 499 |
31 Dec 20 | 11,673 | 1,102 | 2,405 | 519 |
30 Sep 20 | 11,531 | 911 | 2,360 | 516 |
30 Jun 20 | 11,410 | 924 | 2,383 | 528 |
31 Mar 20 | 11,526 | 991 | 2,414 | 552 |
31 Dec 19 | 11,362 | 1,001 | 2,442 | 561 |
30 Sep 19 | 11,156 | 1,335 | 2,348 | 554 |
30 Jun 19 | 11,066 | 1,484 | 2,359 | 573 |
31 Mar 19 | 11,060 | 1,505 | 2,399 | 595 |
31 Dec 18 | 11,099 | 1,552 | 2,401 | 618 |
30 Sep 18 | 11,063 | 1,065 | 2,527 | 636 |
30 Jun 18 | 11,009 | 795 | 2,572 | 632 |
31 Mar 18 | 10,763 | 840 | 2,478 | 621 |
31 Dec 17 | 10,584 | 609 | 2,516 | 615 |
30 Sep 17 | 10,432 | 1,025 | 2,424 | 584 |
30 Jun 17 | 10,283 | 904 | 2,382 | 564 |
31 Mar 17 | 10,263 | 1,852 | 2,447 | 560 |
31 Dec 16 | 10,163 | 4,966 | 2,520 | 566 |
30 Sep 16 | 10,121 | 4,909 | 2,566 | 573 |
30 Jun 16 | 10,050 | 4,784 | 2,625 | 584 |
31 Mar 16 | 9,940 | 3,646 | 2,704 | 582 |
31 Dec 15 | 9,968 | 393 | 2,832 | 589 |
30 Sep 15 | 10,154 | 337 | 2,972 | 585 |
30 Jun 15 | 10,376 | 510 | 3,087 | 593 |
31 Mar 15 | 9,274 | 84 | 3,037 | 473 |
31 Dec 14 | 10,719 | 457 | 3,182 | 608 |
30 Sep 14 | 12,252 | 739 | 3,301 | 743 |
30 Jun 14 | 13,253 | 1,092 | 3,334 | 847 |
31 Mar 14 | 15,367 | 1,967 | 3,437 | 1,047 |
31 Dec 13 | 9,413 | 315 | 2,859 | 534 |
30 Sep 13 | 14,398 | 2,097 | 3,314 | 876 |
30 Jun 13 | 14,165 | 2,152 | 3,239 | 914 |
Quality Earnings: BAX * is currently unprofitable.
Growing Profit Margin: BAX * is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BAX * is unprofitable, and losses have increased over the past 5 years at a rate of 50.2% per year.
Accelerating Growth: Unable to compare BAX *'s earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BAX * is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.7%).
Return on Equity
High ROE: BAX * has a negative Return on Equity (-0.81%), as it is currently unprofitable.